Search Results - "Tatic, A"

Health-Related Quality of Life is Substantially Impaired in Lower-Risk MDS when Compared with Reference Populations and Significantly Affects Overall Survival by Stauder, R, Yu, G, Koinig, K, Fenaux, P, Symeonidis, A, Sanz, G, Cermak, J, Mittelman, M, Hellström-Lindberg, E, Langemeijer, S, Skov Holm, M, Mądry, K, Malcovati, L, Tatic, A, Germing, U, Savic, A, Efficace, F, Smith, A, Bowen, D, de Witte, T

Get full text

Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry by Itzykson, R, Smith, A, Fenaux, P, Symeonidis, A, Mittelman, M, Stauder, R, Sanz, G, Čermák, J, Hellström-Lindberg, E, Malcovati, L, Langemeijer, S, Germing, U, Mądry, K, Holm, M.S, Tatic, A, Almeida, A.M, Savic, A, Gredelj Šimec, N, Bowen, D, de Witte, T

Get full text

212 TRANSFUSIONS AND PRESENCE OF RINGSIDEROBLASTS INFLUENCE HEPCIDIN AND NTBI LEVELS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - A REPORT FROM THE EUROPEAN LEUKEMIANET MDS REGISTRY by de Swart, L, Reiniers, C, Bagguley, T, Van Marrewijk, C, Bowen, D, Cermak, J, Hellström-Lindberg, E, Tatic, A, Symeonidis, A, Huls, G, Panagiotidis, P, Garelius, H, Culligan, D, Krejci, M, Droste, J, Smith, A, Swinkels, D, de Witte, T

Get full text

51 PROGNOSTIC IMPACT OF TRANSFUSION INTENSITY ON SURVIVAL AND THROMBOCYTOPENIA IN NEWLY DIAGNOSED LOWER-RISK MDS PATIENTS PARTICIPATING IN THE EUROPEAN LEUKEMIANET MDS (EUMDS) REGISTRY by de Swart, L, Johnston, W.T, Smith, A, Fenaux, P, Symeonidis, A, Cermak, J, Hellström-Lindberg, E, Sanz, G, Stauder, R, Malcovati, L, Germing, U, Huls, G, Holm, M.S, Mittelman, M, Madry, K, Tatic, A, Almeida, A.M, Savic, A, Park, S, Beyne-Rouzy, O, Itzykson, R, Droste, J, Bowen, D, de Witte, T

Get full text

P-167 New risk group staging according to new R-IPSS of 25 patients with low-risk MDS by Tatic, A, Jardan, C, Georgescu, O, Stanca, O, Vasilica, M, Badelita, S, Crisan, A.M, Colita, A, Colita, D, Vulcan, G, Lupu, A.R, Coriu, D

Get full text

P005 Data from the registry of the patients with myelodysplastic syndrome from Clinic of Hematology, Fundeni Clinical Institute, Bucharest, Romania. V. A comparative analysis: from FAB to WHO classification by Vasilache, D, Moraru, V, Ostroveanu, D, Tatic, A, Georgescu, O, Gologan, R

Get full text

P070 A diagnostic dilemma in a RARS with thrombocytosis and Jak2 negative case – case report by Colita, A, Georgescu, O, Tatic, A, Tuta, A, Ostroveanu, D, Vasilache, D, Moraru, V, Iancu, D, Dobrea, C

Get full text

PO033 Results of the treatment with erythropoietin in myelodysplastic syndrome in 25 patients from a single Romanian center by Tatic, A, Ursuleac, I, Puscariu, T, Gologan, R, Colita, A, Colita, D

Get full text

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study by Stauder, Reinhard, Yu, Ge, Koinig, Karin A., Bagguley, Tim, Fenaux, Pierre, Symeonidis, Argiris, Sanz, Guillermo, Cermak, Jaroslav, Mittelman, Moshe, Hellström-Lindberg, Eva, Langemeijer, Saskia, Holm, Mette Skov, Mądry, Krzysztof, Malcovati, Luca, Tatic, Aurelia, Germing, Ulrich, Savic, Aleksandar, van Marrewijk, Corine, Guerci-Bresler, Agnès, Luño, Elisa, Droste, Jackie, Efficace, Fabio, Smith, Alex, Bowen, David, de Witte, Theo

“…In myelodysplastic syndromes (MDS), health-related quality of life (HRQoL) represents a relevant patient-reported outcome, which is essential in individualized…”
Get full text

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes by de Swart, Louise, Crouch, Simon, Hoeks, Marlijn, Smith, Alex, Langemeijer, Saskia, Fenaux, Pierre, Symeonidis, Argiris, Cermâk, Jaroslav, Hellström-Lindberg, Eva, Stauder, Reinhard, Sanz, Guillermo, Mittelman, Moshe, Holm, Mette Skov, Malcovati, Luca, Mądry, Krzysztof, Germing, Ulrich, Tatic, Aurelia, Savic, Aleksandar, Almeida, Antonio Medina, Gredelj-Simec, Njetocka, Guerci-Bresler, Agnes, Beyne-Rauzy, Odile, Culligan, Dominic, Kotsianidis, Ioannis, Itzykson, Raphael, van Marrewijk, Corine, Blijlevens, Nicole, Bowen, David, de Witte, Theo

“…Progression-free survival (PFS) of patients with lower-risk myelodysplastic syndromes (MDS) treated with red blood cell transfusions is usually reduced, but it…”
Get full text

Inflammatory profile of lower risk myelodysplastic syndromes by Topping, Joanne, Taylor, Adele, Nadat, Fatima, Crouch, Simon, Ibbotson, Alice, Čermák, Jaroslav, Symeonidis, Argiris, Tatic, Aurelia, Langemeijer, Saskia, Hellström‐Lindberg, Eva, Culligan, Dominic, Garelius, Hege Gravdahl, Ashcroft, John, Nga, Emma, Parker, Jane, Kolade, Seye, McDermott, Michael F., De Witte, Theo, Bowen, David, Smith, Alexandra, Cargo, Catherine, Savic, Sinisa

“…Summary The precise link between inflammation and pathogenesis of myelodysplastic syndrome (MDS) is yet to be fully established. We developed a novel method to…”
Get full text

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes by de Swart, Louise, Reiniers, Chloé, Bagguley, Timothy, van Marrewijk, Corine, Bowen, David, Hellström-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Huls, Gerwin, Cermak, Jaroslav, van de Loosdrecht, Arjan A, Garelius, Hege, Culligan, Dominic, Macheta, Mac, Spanoudakis, Michail, Panagiotidis, Panagiotis, Krejci, Marta, Blijlevens, Nicole, Langemeijer, Saskia, Droste, Jackie, Swinkels, Dorine W, Smith, Alex, de Witte, Theo

“…Red blood cell transfusions remain one of the cornerstones in supportive care of lower-risk patients with myelodysplastic syndromes. We hypothesized that…”
Get full text

O08 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: LYMPHOPENIA IS HIGHLY PREVALENT IN MDS AND PROVIDES ADDITIONAL PROGNOSTIC INFORMATION FOR IPSS-R VERY-LOW AND LOW-RISK PATIENTS. AN ANALYSIS FROM THE EU-MDS REGISTRY by Silzle, T., Taylor, A., De Witte, T., Malcovati, L., Fenaux, P., Bowen, D., Symeonidis, A., Mittelman, M., Stauder, R., Cermak, J., Sanz, G., Hellström-Lindberg, E., Langemeijer, S., Holm, M. Skov, Madry, K., Tatic, A., Almeida, A. Medina, Savic, A., Rogulj, I. Mandac, Germing, U., Smith, A.

Get full text

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment by Silzle, T., Taylor, A., De Witte, T., Malcovati, L., Fenaux, P., Bowen, D., Symeonidis, A., Mittelman, M., Stauder, R., Cermak, J., Sanz, G., Hellström-Lindberg, E., Langemeijer, S., Holm, M. Skov, Madry, K., Tatic, A., Almeida, A. Medina, Savic, A., Rogulj, I. Mandac, Germing, U., Smith, A.

Get full text

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival by Hoeks, Marlijn, Bagguley, Tim, Roelofs, Rian, De Swart, Louise, Bowen, David, Symeonidis, Argiris, van Marrewijk, Corine, Hellström-Lindberg, Eva, Tatic, Aurelia, Langemeijer, Saskia, Culligan, Dominic J., Macheta, Marian, Garelius, Hege, Spanoudakis, Michail, Killick, Sally, Panagiotidis, Panagiotis, Stanca Ciocan, Oana, Mills, Juliet, Pottinger, Bryson, Ackroyd, Sam, Hall, Claire, Droste, Jackie, Smith, Alexandra, Swinkels, Dorine W., de Witte, Theo M

“…Background: Patients with lower-risk MDS (LR-MDS) are prone to iron toxicity due to long-term iron accumulation either caused by RBC transfusions or…”
Get full text

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry by Langemeijer, Saskia, De Swart, Louise, Yu, Ge, Smith, Alex, Crouch, Simon, Johnston, Tom, Fenaux, Pierre, Symeonidis, Argiris, Cermak, Jaroslav, Hellstrom-Lindberg, Eva, Sanz, Guillermo, Stauder, Reinhard, Malcovati, Luca, Germing, Ulrich, Skov Holm, Mette, Mittelman, Moshe, Madry, Krzysztof, Tatic, Aurelia, Almeida, Antonio, Savic, Aleksandar, Park, Sophie, Beyne-Rauzy, Odile, Itzykson, Raphaël, van Marrewijk, Corine, Bowen, David, de Witte, Theo

“…▪ Background Overall survival (OS) of lower-risk myelodysplastic syndrome (LR-MDS) patients treated with red blood cell transfusions (RBCT) is inferior to that…”
Get full text

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance by de Swart, Louise, Smith, Alex, MacKenzie, Marius, Symeonidis, Argiris, Neukirchen, Judith, Mikulenková, Dana, Vallespí, Teresa, Zini, Gina, Paszkowska-Kowalewska, Malgorzata, Kruger, Anton, Saft, Leonie, Fenaux, Pierre, Bowen, David, Hellström-Lindberg, Eva, Čermák, Jaroslav, Stauder, Reinhard, Tatic, Aurelia, Holm, Mette Skov, Malcovati, Luca, Mądry, Krzysztof, Droste, Jackie, Blijlevens, Nicole, de Witte, Theo, Germing, Ulrich

“…The European LeukemiaNet MDS (EUMDS) registry is collecting data of myelodysplastic syndrome (MDS) patients belonging to the IPSS low or intermediate-1…”
Get full text

Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry by De Swart, Louise, Reiniers, Chloé, Bagguley, Tim, Bowen, David, Cermak, Jaroslav, Hellström-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Huls, Gerwin, Panagiotidis, Panagiotis, Garelius, Hege, Culligan, Dominic, Krejci, Marta, van Marrewijk, Corine, Droste, Jackie, Smith, Alexandra, Swinkels, Dorine W., de Witte, Theo

“…Background: The EUMDS registry collects prospective observational data on lower-risk MDS patients from 142 centers in 17 countries. Red blood cell (RBC)…”
Get full text

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS by de Swart, Louise, Smith, Alex, Haase, Detlef, Fenaux, Pierre, Symeonidis, Argiris, Cermak, Jaroslav, Sanz, Guillermo, Stauder, Reinhard, Mittelman, Moshe, Hellström-Lindberg, Eva, Malcovati, Luca, Langemeijer, Saskia, Skov-Holm, Mette, Mądry, Krzysztof, Germing, Ulrich, Almeida, Antonio Medina, Tatic, Aurelia, Savic, Aleksandar, Šimec, Njetočka Gredelj, van Marrewijk, Corine, Guerci-Bresler, Agnes, Sanhes, Laurence, Luño, Elisa, Culligan, Dominic, Beyne-Rauzy, Odile, Burgstaller, Sonja, Blijlevens, Nicole, Bowen, David, de Witte, Theo

“…•Outcome in normal karyotype and suboptimal number of metaphases was not inferior.•Abnormal karyotype and suboptimal number of metaphases did not impact…”
Get full text

19 - Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry by Itzykson, R., Smith, A., Fenaux, P., Symeonidis, A., Mittelman, M., Stauder, R., Sanz, G., Čermák, J., Hellström-Lindberg, E., Malcovati, L., Langemeijer, S., Germing, U., Mądry, K., Holm, M.S., Tatic, A., Almeida, A.M., Savic, A., Gredelj Šimec, N., Bowen, D., de Witte, T.

Get full text